Artificial Policy

The Journal of Life Sciences and Biomedicine (JLSB) recognizes the increasing role of artificial intelligence (AI) technologies in scientific research, scholarly communication, and academic publishing. The journal supports the responsible, transparent, and ethically appropriate use of AI-assisted tools while maintaining the principles of scientific integrity, human accountability, and academic transparency.

This policy applies to all authors, reviewers, editors, and contributors participating in the editorial and publication process.

AI Use by Authors

Authors may use AI-assisted technologies and language-support tools, including applications designed for:

• Language editing and grammar improvement 
• Translation assistance 
• Data organization and computational support 
• Coding assistance and technical formatting 

provided that all AI-assisted output is critically reviewed, verified, and supervised by the authors.

Authors remain fully responsible for:

• The originality and accuracy of submitted content 
• Scientific interpretation and conclusions 
• Ethical compliance and integrity of the work 
• Verification of all data, analyses, and references 

The intellectual responsibility for the manuscript must remain entirely with the human authors.

Disclosure Requirements

Authors must transparently disclose the use of AI tools if such technologies contributed to:

• Content generation 
• Data analysis 
• Image generation 
• Translation or substantial language editing 
• Computational or methodological assistance 

Disclosure statements should be included within the manuscript, typically in the Acknowledgements, Methods, or a dedicated declaration section.

Example:

“Artificial intelligence-assisted tools were used solely to support language editing and manuscript preparation under the direct supervision and verification of the authors.”

Failure to disclose substantial AI-assisted contributions may be considered a breach of publication ethics.

Prohibited Uses of AI

The following practices are strictly prohibited:

• Submission of AI-generated scientific content without human verification 
• Fabrication, falsification, or manipulation of scientific data using AI tools 
• Undisclosed AI-generated figures, images, or results 
• Automated generation of misleading or fraudulent research findings 
• Listing AI systems, chatbots, or software as authors or co-authors 

AI technologies cannot meet authorship criteria because they cannot assume responsibility for scholarly integrity, ethical accountability, or conflicts of interest.

AI Use in Peer Review and Editorial Processes

Reviewers and editors must preserve the confidentiality of submitted manuscripts and unpublished materials at all times.

Reviewers are prohibited from uploading confidential manuscript content, reviewer reports, or unpublished data into publicly accessible AI systems or external generative AI platforms.

Editors may use limited AI-assisted tools for administrative support, language review, reference formatting, or plagiarism screening only when confidentiality, data protection, and ethical standards are fully maintained.

All editorial decisions, peer review evaluations, and publication judgments are made exclusively by human editors and qualified reviewers.

Research Integrity and Accountability

The use of AI technologies does not diminish the responsibility of authors, reviewers, or editors to uphold the highest standards of scientific integrity, transparency, and ethical conduct.

Any misuse of AI technologies that compromises scientific reliability, publication ethics, or research authenticity may result in:

• Manuscript rejection 
• Retraction of published articles 
• Editorial sanctions 
• Notification of affiliated institutions where appropriate 

Policy Updates

The Journal of Life Sciences and Biomedicine (JLSB) continuously monitors developments in artificial intelligence technologies and scholarly publishing standards. This policy may be revised periodically in accordance with international best practices, publication ethics recommendations, and emerging regulatory guidance.